The Economist Podcasts

Shot chasers: big pharma’s covid-19 boost

The Economist Podcasts

The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory’s increasingly fraught politics. 

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer

 

See acast.com/privacy for privacy and opt-out information.

Next Episodes

The Economist Podcasts

The World Ahead: After Kim Jong-un @ The Economist Podcasts

📆 2020-05-25 17:30 / 00:25:01



The Economist Podcasts

Editor’s Picks: May 25th 2020 @ The Economist Podcasts

📆 2020-05-25 01:00 / 00:22:29


The Economist Podcasts

Checks and Balance: Fab phwoar @ The Economist Podcasts

📆 2020-05-22 19:14 / 00:37:53